Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma-Reference-Cited by-同舟云学术

Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma

Published:2017-03-04 Issue:5 Volume:24 Page:361-366
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Fukushi Ken¹,Narita Takuma¹,Hatakeyama Shingo¹,Yamamoto Hayato¹,Tobisawa Yuki¹,Yoneyama Tohru²,Yoneyama Takahiro¹,Hashimoto Yasuhiro²,Koie Takuya¹,Ohyama Chikara¹²

Affiliation:

1. Department of Urology; Hirosaki University Graduate School of Medicine; Hirosaki Japan

2. Department of Advanced Transplant and Regenerative Medicine; Hirosaki University Graduate School of Medicine; Hirosaki Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/iju.13318/fullpdf

Reference20 articles.

1. New frontiers in patient-reported outcomes: adverse event reporting, comparative effectiveness, and quality assessment;Basch;Annu. Rev. Med.,2014

2. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials;Di Maio;J. Clin. Oncol.,2015

3. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30;Fromme;J. Clin. Oncol.,2004

4. Patient-reported outcomes in the evaluation of toxicity of anticancer treatments;Di Maio;Nat. Rev. Clin. Oncol.,2016

5. The missing voice of patients in drug-safety reporting;Basch;N. Engl. J. Med.,2010

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reliability, validity, and change thresholds of the NCCN/FACT Bladder Symptom Index (NFBlSI‐18) in patients with advanced urothelial cancer;Cancer;2023-10-12

2. Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis;Cancers;2021-09-24

3. Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the ‘TOaSTT’ database;Radiation Oncology;2021-01-06

4. Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study);International Journal of Clinical Oncology;2020-10-16

5. Documentation of Symptoms in Children Newly Diagnosed With Cancer Highlights the Need for Routine Assessment Using Self-report;Cancer Nursing;2020-07-02